eledon-logo-1230.png
Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS
October 24, 2022 16:05 ET | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that the Company will present two posters at the upcoming American Society...
12-year-old Boy from
12-year-old Boy from Waterloo, Iowa Wins American Kidney Fund National Art Contest for Pediatric Kidney Patients
October 06, 2022 11:10 ET | American Kidney Fund
ROCKVILLE, Md., Oct. 06, 2022 (GLOBE NEWSWIRE) -- A young kidney transplant recipient from Waterloo, IA has won the American Kidney Fund’s (AKF) 27th annual national Calendar Kids Art Contest....
eledon-logo-1230.png
Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
October 03, 2022 08:00 ET | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming conferences: A...
American Kidney Fund
American Kidney Fund’s New APOL1-Mediated Kidney Disease Campaign Aims to Educate and Increase Awareness About APOL1 Gene Mutations
September 27, 2022 08:57 ET | American Kidney Fund
ROCKVILLE, Md., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today launched its new APOL1 campaign, which aims to educate and increase awareness about APOL1-mediated kidney...
eledon-logo-1230.png
Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
September 22, 2022 16:05 ET | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate in...
Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2022 Corporate Membership Program at ‘Champion’ Level
September 19, 2022 11:27 ET | American Kidney Fund
ROCKVILLE, Md., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2022 class in AKF’s Corporate...
American Kidney Fund
American Kidney Fund, Home Dialyzors United Partner to Host Dialysis at Home Summit
September 13, 2022 16:26 ET | American Kidney Fund
ROCKVILLE, Md., Sept. 13, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host...
eledon-logo-1230.png
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
September 06, 2022 16:01 ET | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's...
eledon-logo-1230.png
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
August 29, 2022 08:00 ET | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor...
eledon-logo-1230.png
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
August 11, 2022 16:01 ET | Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application for Phase 2 trial evaluating tegoprubart for the prevention of rejection in kidney transplant recipients First patient dosed in Phase 1b trial evaluating...